An Evaluation of the NJSPB SCF Project for Opioid-Involved High-Risk Parolees

• ClinicalTrials.gov Identifier: NCT03812484
• Recruitment Status: Active, not recruiting
• First Posted: January 23, 2019
• Last Update Posted: February 2, 2021
• Sponsor: Botec Analysis, LLC
• Information provided by (Responsible Party): Clarissa Manning, Botec Analysis, LLC

Study Description

Brief Summary:

This study entails an evaluation of the New Jersey State Parole Board Swift, Certain, and Fair (SCF) Supervision Program. The purpose of the evaluation is to test whether subjects assigned to SCF Supervision perform better than those assigned to parole-as-usual (PAU).

Condition or disease	Intervention/treatment	Phase
Substance Abuse; Criminal Behavior	Behavioral: SCF Supervision; Behavioral: Parole-as-Usual	Not Applicable

Detailed Description:

The Swift, Certain, and Fair (SCF) Supervision Program - Including Project HOPE Program provides funding to states, units of local government, territories, and federally recognized Indian tribes (as determined by the Secretary of the Interior) in an effort to enhance public safety, foster collaboration, and to improve the outcomes of individuals under the supervision of community corrections. The goals of this program are to develop and enhance SCF initiatives and implement the SCF model with fidelity, resulting in reduced recidivism and better outcomes for program participants. SCF approaches are intended to: (a) improve supervision strategies that reduce recidivism; (b) promote and increase collaboration among agencies and officials who work in community corrections and related fields to enhance swift and certain sanctions; (c) enhance the offenders' perception that the supervision decisions are fair, consistently applied, and consequences are transparent; and (d) improve the outcomes of individuals participating in these initiatives. The grantee will use awarded grant funds to support programming that provides services to up to 75 opioid involved parolees with services to divert them from a return to prison and manage underlying addictions with a combination of behavioral therapy and medication assisted treatments. The program combines sanctions with targeted reentry and treatment services.

Study Design

• Study Type: Interventional (Clinical Trial)
• Actual Enrollment: 77 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: None (Open Label)
• Primary Purpose: Prevention
• Official Title: An Evaluation of the New Jersey State Parole Board Swift, Certain, and Fair Project for Opioid-Involved High-Risk Parolees
• Actual Study Start Date: February 1, 2019
• Actual Primary Completion Date: December 31, 2020
• Estimated Study Completion Date: March 31, 2021

Arms and Interventions

Arm	Intervention/treatment
Experimental: SCF Parole; Parolee supervised under the SCF Supervision model	Behavioral: SCF Supervision; SCF Supervision entails a warning session (Orientation Hearing) where the rules of parole are laid out and parolees are told that any violation of stated parole conditions will be sanctioned with a brief jail term (typically a few days in jail). SCF Supervision includes regular random drug testing.
Active Comparator: Parole-As-Usual; Parolees are supervised under standard parole supervision practice in New Jersey.	Behavioral: Parole-as-Usual; Parolees are supervised under standard parole supervision practice in New Jersey; Other Name: PAU

Outcome Measures

Primary Outcome Measures :

1. Revocation Rate [ Time Frame: 12 months ]
   Percentage of subjects in each condition who are revoked from parole and returned to prison

Secondary Outcome Measures :

1. Days Incarcerated [ Time Frame: 12 months ]
   Total number of days incarcerated in jail or prison
2. New Charges [ Time Frame: 12 months ]
   Number of new charges
3. Percent Positive Drug Tests [ Time Frame: 12 months ]
   Percentage of random and scheduled drug tests that test positive for illicit drugs

Eligibility Criteria

• Ages Eligible for Study: 18 Years and older (Adult, Older Adult)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Criteria

Inclusion Criteria:

• Participants must be 18 years of age or older
• Participants must have a history of opioid use or addiction
• Participants have a history of parole violations or active parolees who are at risk for violation (this can include anyone who is reentering the active population from prison)
• Participants reside in or are moving to Ocean County; and
• Participants must have at least 6 months remaining on their Parole term

Exclusion Criteria:

-

Contacts and Locations

Locations

United States, New Jersey

New Jersey Reentry Corporation

Toms River, New Jersey, United States, 08753

Sponsors and Collaborators

Botec Analysis, LLC

Investigators

• Principal Investigator: Clarissa Manning, MPP; Botec Analysis, LLC

More Information

• Responsible Party: Clarissa Manning, Director of Business Operations, Botec Analysis, LLC
• ClinicalTrials.gov Identifier: NCT03812484
• Other Study ID Numbers: CC100
• First Posted: January 23, 2019
• Last Update Posted: February 2, 2021
• Last Verified: January 2021

Individual Participant Data (IPD) Sharing Statement:

• Plan to Share IPD: No

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:

Substance-Related Disorders; Chemically-Induced Disorders; Mental Disorders